RALA and cardiovascular disorder: In conclusion, this study suggests a switch to an N(t)RTI-sparing cART regimen consisting of r/LPV plus RAL has a similar affect on limb fat and cardiovascular disease risk compared with r/LPV plus N(t)RTIs, but may worsen the lipid profile.